Literature DB >> 31784915

Cognitive Intelligence Assisted Fog-Cloud Architecture for Generalized Anxiety Disorder (GAD) Prediction.

Ankush Manocha1, Ramandeep Singh2, Munish Bhatia1.   

Abstract

Generalized Anxiety Disorder (GAD) is a psychological disorder caused by high stress from daily life activities. It causes severe health issues, such as sore muscles, low concentration, fatigue, and sleep deprivation. The less availability of predictive solutions specifically for individuals suffering from GAD can become an imperative reason for health and psychological adversity. The proposed solution aims to monitor health, behavioral and environmental parameters of the individual to predict health adversity caused by GAD. Initially, Weighted-Naïve Bayes (W-NB) classifier is utilized to predict irregular health events by classifying the captured data at the fog layer. The proposed two-phased decision-making process helps to optimize the distribution of required medical services by determining the scale of vulnerability. Furthermore, the utility of the framework is increased by calculating health vulnerability index using Adaptive Neuro-Fuzzy Inference System-Genetic Algorithm (ANFIS-GA) on the cloud. The presented work addresses the concerns in terms of efficient monitoring of anomalies followed by time sensitive two-phased alert generation procedure. To approve the performance of irregular event identification and health severity prediction, the framework has been conveyed in a living room for 30 days in which almost 15 individuals by the age of 68 to 78 years have been continuously monitored. The calculated outcomes represent the monitoring efficiency of the proposed framework over the policies of manual monitoring.

Entities:  

Keywords:  Cognitive intelligence; Fog computing; Generalized anxiety disorder (GAD); Internet of things

Mesh:

Year:  2019        PMID: 31784915     DOI: 10.1007/s10916-019-1495-y

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  16 in total

Review 1.  Comorbidity of depression and anxiety disorders in later life.

Authors:  E J Lenze; B H Mulsant; M K Shear; G S Alexopoulos; E Frank; C F Reynolds
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

2.  Cornell Scale for Depression in Dementia.

Authors:  G S Alexopoulos; R C Abrams; R C Young; C A Shamoian
Journal:  Biol Psychiatry       Date:  1988-02-01       Impact factor: 13.382

3.  Large-Scale Cross-Modality Search via Collective Matrix Factorization Hashing.

Authors: 
Journal:  IEEE Trans Image Process       Date:  2016-09-08       Impact factor: 10.856

4.  Housing quality, housing instability, and maternal mental health.

Authors:  Shakira Franco Suglia; Cristiane S Duarte; Megan T Sandel
Journal:  J Urban Health       Date:  2011-12       Impact factor: 3.671

5.  Cognitive functions in young adults with generalized anxiety disorder.

Authors:  Kiara Leonard; Amitai Abramovitch
Journal:  Eur Psychiatry       Date:  2018-11-17       Impact factor: 5.361

6.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

Review 7.  Generalized anxiety disorder and medical illness.

Authors:  Larry Culpepper
Journal:  J Clin Psychiatry       Date:  2009       Impact factor: 4.384

8.  Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study.

Authors:  R A Schoevers; A T F Beekman; D J H Deeg; C Jonker; W van Tilburg
Journal:  Int J Geriatr Psychiatry       Date:  2003-11       Impact factor: 3.485

9.  A structured interview guide for the Hamilton Depression Rating Scale.

Authors:  J B Williams
Journal:  Arch Gen Psychiatry       Date:  1988-08

10.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.